Walgreens on Thursday said it will start to work directly with drugmakers to bring cell and gene therapies to U.S. patients as part of a broader expansion of its specialty pharmacy services.
The company said it is launching a new business unit dedicated to its specialty pharmacy segment, which will include specialty pharmacy subsidiary AllianceRx.
Meanwhile, Shields Health Solutions, a subsidiary that supports health system-owned specialty pharmacies, will remain under Walgreens's U.S. health-care division.
Specialty pharmacies provide medications that require extreme care in handling, storage and distribution.
Among the company's new investments to "transform" its specialty pharmacy services, it will open a newly licensed facility in Pittsburgh dedicated to services for cell and gene therapies.
Persons:
drugmakers
Organizations:
Walgreens, Walgreens Boots Alliance, Shields Health Solutions, Walgreens's
Locations:
Manhattan , New York City, U.S, Pittsburgh